Treatment of Tetracycline-Resistant Mycoplasma Infections

Diagnosis and Treatment Strategies

The European Urology guidelines recommend confirming whether the infection is tetracycline-resistant or macrolide-resistant before treatment 1

For tetracycline-resistant Mycoplasma infections, the European Urology guidelines recommend moxifloxacin 400 mg once daily for 7-14 days as a second-line treatment option 1
The MMWR Recommendations and Reports suggest that pristinamycin 1 g four times daily for 10 days, with a cure rate of approximately 75%, can be used as a third-line treatment option after moxifloxacin treatment failure 2
The MMWR Recommendations and Reports also recommend that doxycycline or minocycline 100 mg twice daily for 14 days, with a cure rate of approximately 40-70%, can be used as alternative treatment options 2

The MMWR Recommendations and Reports guidelines advise against using single-dose azithromycin (1g) for treatment, as it may increase the development of macrolide resistance 2
The European Urology and MMWR Recommendations and Reports guidelines recommend that sexual partners should be evaluated and treated to prevent reinfection 1, 2, 3
The MMWR Recommendations and Reports guidelines suggest that patients should avoid sexual activity during treatment and for 7 days after completion of treatment to prevent transmission 2

The MMWR Recommendations and Reports guidelines recommend that patients with persistent or recurrent symptoms should be re-evaluated 2
The MMWR Recommendations and Reports guidelines suggest that test-of-cure is recommended 3-6 months after treatment, regardless of whether the patient's sexual partner has been treated 2